Although relatively uncommon, malignant hyperthermia (MH) can be a life-threatening crisis when it occurs intraoperatively or postoperatively. It is imperative that every member of the perianesthesia team knows what to do and works cohesively because it is a true emergency. This article reviews information for perianesthesia nurses, perioperative nurses, and anesthesia providers about agents that trigger MH; early and late symptoms of MH; recommended medications, equipment, and emergency supplies that should be readily available for use; and the recommended protocol for effectively treating MH.
Objectives: -Based on the content of this article, the reader should be able to (1) describe the pathophysiology of malignant hyperthermia (MH); (2) identify the triggering agents of MH; (3) identify patients at risk for MH; (4) describe the early and late signs of MH; (5) state the medication of choice to treat MH; and (6) describe perianesthesia and/or perioperative nursing interventions for treating an MH patient.
Copyright 2001 by American Society of PeriAnesthesia Nurses.